Scientific sessions

Home » Scientific Sessions

Scientific Session Day 1
Scientific Session Day 2
Scientific Session Day 3

Session 1Advances in Cancer Imaging Techniques

Advances in cancer imaging have significantly improved detection, diagnosis, and treatment. Molecular imaging techniques like PET/CT and PET/MRI provide functional and molecular insights, aided by new radiotracers such as PSMA for prostate cancer. Functional MRI (fMRI) and diffusion-weighted imaging (DWI) assess tumor vasculature and cellularity, offering critical data for therapy planning. Spectral and photon-counting CT enhance tissue differentiation while reducing radiation exposure. Ultrasound innovations, including contrast-enhanced ultrasound and elastography, improve sensitivity in detecting vascularity and distinguishing malignancies. Optical imaging techniques like fluorescence-guided surgery and OCT enable precise tumor visualization and resection. AI in imaging improves interpretation accuracy, automates tumor segmentation, and predicts treatment outcomes. Liquid biopsy-integrated imaging offers non-invasive monitoring of tumor dynamics. Theranostic imaging and nanotechnology enhance simultaneous imaging and treatment capabilities. Whole-body PET scanners provide comprehensive cancer assessments with reduced radiation, advancing personalized cancer care.

Session 2Radiation Therapy: Innovations and Best Practices

Radiation therapy has advanced significantly, improving precision and minimizing side effects. Techniques like intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) deliver targeted doses, sparing healthy tissues. Image-guided radiation therapy (IGRT) and adaptive radiation therapy (ART) enhance tumor targeting and adjust for changes during treatment. Proton therapy offers precise energy delivery, benefiting pediatric and complex cancers. Emerging innovations like FLASH radiation therapy show promise for reducing side effects with ultra-high-dose delivery. Artificial intelligence aids in treatment planning, dose optimization, and error detection. Best practices emphasize multidisciplinary collaboration, patient-centered care, and rigorous quality assurance. These advancements ensure safer, more effective cancer treatment and improved patient outcomes.

Session 3Molecular Imaging in Cancer Detection

Molecular imaging has transformed cancer detection by providing detailed insights into tumor biology and metabolism. Techniques like PET and PET/CT use radiotracers such as FDG to highlight areas of abnormal metabolic activity. PET/MRI combines functional imaging with superior soft-tissue contrast for precise tumor localization. Emerging radiotracers, including PSMA for prostate cancer, target specific biomarkers for improved accuracy. SPECT imaging complements these advances by visualizing molecular pathways. Optical imaging techniques like fluorescence imaging enhance tumor detection during surgery. AI-driven analysis improves image interpretation and early diagnosis. Molecular imaging also enables monitoring of treatment response in real time. Combining imaging with liquid biopsies offers a non-invasive approach to track cancer progression. These innovations advance early detection, personalized treatment, and better patient outcomes.

Session 4Precision Medicine in Cancer Treatment

Precision medicine is revolutionizing cancer treatment by tailoring therapies to individual genetic and molecular profiles. Advances in genomic sequencing identify mutations driving cancer, enabling targeted therapies like EGFR inhibitors for lung cancer and HER2 inhibitors for breast cancer. Immunotherapies, including checkpoint inhibitors and CAR-T cells, leverage patients’ immune systems for precise tumor attacks. Molecular diagnostics and liquid biopsies provide non-invasive tools to monitor tumor evolution and resistance. Biomarkers guide treatment selection, ensuring optimal efficacy with minimal side effects. Artificial intelligence enhances precision by analyzing complex datasets for personalized treatment plans. Combination therapies integrate targeted drugs with traditional methods like chemotherapy for better outcomes. Precision medicine emphasizes patient-centric care, improving survival rates and quality of life. Ongoing research continues to expand therapeutic options, paving the way for more effective and individualized cancer care.

Session 5The Role of AI in Cancer Radiology

Artificial intelligence (AI) is transforming cancer radiology by enhancing accuracy, efficiency, and early detection. AI-powered algorithms analyze medical images to detect subtle abnormalities that may be missed by human eyes, improving diagnostic precision. Machine learning models assist in tumor segmentation, enabling more accurate treatment planning. AI streamlines workflows by automating time-intensive tasks like contouring and image registration. Predictive analytics assess tumor behavior and treatment response, aiding in personalized care. AI also integrates multimodal data, such as imaging and genomics, for comprehensive cancer profiling. Deep learning enhances image quality and reduces noise, improving diagnostic clarity. Radiomics, powered by AI, extracts quantitative features from images for better risk stratification. By reducing errors and enhancing decision-making, AI supports radiologists in delivering precise, patient-centered care. These advancements position AI as a vital tool in the fight against cancer.

Session 6Early Detection of Cancer through Imaging

Early detection of cancer through imaging significantly improves survival rates by identifying tumors at treatable stages. Techniques like mammography and low-dose CT scans are vital for breast and lung cancer screening. Ultrasound and MRI are used to detect abnormalities in dense tissues and organs. PET/CT imaging identifies metabolic changes, often before structural changes occur. Advanced technologies, such as liquid biopsy-integrated imaging, enhance non-invasive early diagnosis. AI-driven tools improve sensitivity and accuracy, detecting subtle changes that may indicate early cancer. Functional imaging methods, like diffusion-weighted MRI, assess tumor cellularity, aiding in detection. Optical imaging, including fluorescence-guided methods, is particularly effective for early-stage cancers like skin and oral tumors. Screening programs using advanced imaging modalities help identify high-risk populations. These innovations collectively enhance early detection, enabling timely and effective intervention.

Session 7Imaging Biomarkers in Cancer Prognosis

Imaging biomarkers play a crucial role in cancer prognosis by providing insights into tumor characteristics and treatment response. Techniques like PET and MRI identify metabolic and molecular changes, offering prognostic information about tumor aggressiveness. Tumor volume, shape, and texture, derived from imaging, correlate with patient outcomes and survival rates. Diffusion-weighted MRI (DWI) and functional MRI (fMRI) assess tumor microenvironment, revealing cellularity and blood flow, key indicators of prognosis. PET/CT imaging helps evaluate the spread of cancer, assisting in staging and predicting recurrence. Radiomics extracts quantitative features from imaging to predict treatment response and survival. Tumor heterogeneity, observed through imaging biomarkers, informs personalized treatment decisions. AI algorithms analyze imaging data to enhance prognostic accuracy. By identifying early changes in tumor behavior, imaging biomarkers aid in adjusting treatment plans for better outcomes. These advances in imaging enhance the ability to predict cancer prognosis and guide therapeutic strategies.

Session 8Radiomics: Exploring Data in Cancer Radiology

Radiomics is revolutionizing cancer radiology by extracting quantitative data from medical images to improve diagnosis, prognosis, and treatment planning. Using advanced algorithms, radiomics analyzes features such as texture, shape, and intensity, providing insights beyond visual appearance. These features correlate with tumor biology, helping predict tumor behavior and treatment response. The integration of radiomics with genomics and clinical data enhances personalized treatment strategies. AI and machine learning play a critical role in processing large radiomics datasets, identifying patterns that can guide clinical decisions. Radiomics also aids in assessing tumor heterogeneity, a key factor in understanding cancer progression. By tracking changes in imaging biomarkers, radiomics can monitor treatment response and detect early recurrence. This non-invasive approach offers a cost-effective alternative to traditional biopsies. The field continues to evolve, with ongoing research aiming to refine radiomic models for greater accuracy. Ultimately, radiomics holds the potential to transform cancer care by enabling more precise, individualized treatment plans.

Session 9Targeted Radiotherapy: Current Approaches

Targeted radiotherapy is an emerging approach in cancer treatment that delivers precise radiation to tumor cells while minimizing damage to surrounding healthy tissue. Techniques such as intensity-modulated radiation therapy (IMRT) and proton therapy allow for highly focused beams, enhancing tumor targeting and sparing healthy organs. Stereotactic body radiotherapy (SBRT) delivers high doses of radiation to small tumors with minimal risk of side effects. Radiopharmaceuticals, including targeted radionuclide therapy, use radioactive substances that specifically bind to cancer cells, delivering radiation directly to the tumor. Advances in imaging, like PET/CT, enable real-time tumor localization for more accurate radiation delivery. Personalized treatment plans are developed by combining genetic profiling with imaging to identify patients who will benefit most from targeted radiotherapy. The integration of immunotherapy with targeted radiotherapy enhances treatment effectiveness by boosting the immune system’s response to the tumor. Combining targeted radiotherapy with chemotherapy and other systemic therapies improves overall outcomes. Research continues to refine targeted radiotherapy techniques, optimizing dosing and delivery methods. These innovations hold great promise for improving cancer treatment by increasing precision and reducing side effects.

Session 10Radiotherapy in Personalized Cancer Care

Radiotherapy in personalized cancer care tailors treatment plans to individual patients based on their unique genetic, molecular, and tumor characteristics. Advances in genomic profiling allow for the identification of specific mutations and biomarkers that guide the choice of radiotherapy modalities, ensuring better treatment efficacy. Techniques like intensity-modulated radiation therapy (IMRT) and proton therapy deliver highly focused doses, minimizing damage to surrounding healthy tissue. Personalized treatment plans also incorporate advanced imaging methods, such as PET/CT, to accurately target tumors and monitor their response. Biomarker-driven strategies enhance the selection of patients who will benefit most from radiotherapy. Combining radiotherapy with immunotherapy and targeted therapies improves outcomes by activating the immune system to target cancer cells. AI and machine learning analyze large datasets to predict patient responses and optimize treatment schedules. Personalized radiotherapy also involves adjusting radiation doses based on the tumor’s size, location, and sensitivity. By customizing radiotherapy approaches, patients experience fewer side effects and improved survival rates. Personalized radiotherapy is transforming cancer treatment, offering more effective, tailored, and less invasive options for patients.

Session 11Advances in 3D Imaging for Cancer Diagnosis

Advances in 3D imaging have revolutionized cancer diagnosis by providing more detailed and accurate representations of tumors. Techniques like 3D CT and MRI scans create high-resolution images, allowing for better visualization of tumor size, shape, and location. 3D imaging enhances the ability to detect small tumors that might be missed in traditional 2D imaging. Functional imaging methods, such as 3D PET/CT, offer insights into tumor metabolism and biology, aiding in precise diagnosis and staging. Stereotactic biopsy procedures are guided by 3D imaging, ensuring accurate tissue sampling from hard-to-reach areas. 3D ultrasound technology improves tumor localization and assists in monitoring treatment response. The integration of AI with 3D imaging further enhances accuracy, automating tumor segmentation and tracking changes over time. Virtual reality and 3D reconstruction allow clinicians to interact with tumor data in a more intuitive and precise way. This technology supports personalized treatment planning, tailoring therapies to the tumor’s 3D structure. Overall, 3D imaging is a powerful tool in early cancer detection, precise staging, and monitoring treatment efficacy.

Session 12The Role of MRI in Cancer Diagnosis and Treatment

MRI plays a vital role in cancer diagnosis and treatment by providing detailed, high-resolution images of soft tissues without the need for radiation. It is especially valuable in detecting and characterizing tumors in areas such as the brain, liver, breast, and prostate. MRI helps in accurately determining tumor size, shape, and location, guiding biopsy procedures and surgical planning. Advanced techniques like functional MRI (fMRI) and diffusion-weighted imaging (DWI) assess tumor microenvironment, cellularity, and blood flow, which are critical for treatment planning. Additionally, MRI is used to monitor treatment response, detect recurrence, and assess post-treatment effects, offering real-time insights into how the tumor is reacting to therapies. With the integration of contrast agents and innovations in MRI technologies, it continues to be a cornerstone in personalized cancer care, enabling precise, non-invasive evaluation and monitoring.

Session 13PET/CT Imaging in Oncology: Latest Developments

PET/CT imaging has become a crucial tool in oncology for both diagnosing and monitoring cancer. The combination of positron emission tomography (PET) and computed tomography (CT) provides detailed information about the metabolic activity of tumors (from PET) and their precise anatomic location (from CT). The latest developments in PET/CT imaging include the use of novel radiotracers, such as PSMA for prostate cancer, which enhances tumor detection and staging. Improved image resolution and faster scanning techniques have made PET/CT more effective in detecting small tumors, assessing treatment response, and identifying recurrence. Hybrid imaging systems are now more widely available, allowing for better integration of molecular and anatomical data. Advances in AI and machine learning are also aiding in the interpretation of PET/CT scans, improving diagnostic accuracy and enabling more personalized treatment plans for cancer patients. These innovations continue to enhance the ability to assess tumor biology, stage cancers more accurately, and monitor therapeutic outcomes in real-time.

Session 14Radiation Safety and Protection in Oncology

Radiation safety and protection in oncology are critical to ensuring the safety of both patients and healthcare professionals during radiation-based cancer treatments. To minimize radiation exposure, advanced techniques such as intensity-modulated radiation therapy (IMRT) and proton therapy are used, which deliver highly targeted radiation to tumors while sparing surrounding healthy tissue. Strict protocols are followed for dose calculation, and shielding devices, such as lead barriers, are used to protect non-targeted areas. Regular quality assurance checks ensure the accuracy of radiation delivery equipment. For patients, protective measures include limiting radiation exposure to healthy tissues and carefully planning the treatment course. Healthcare providers undergo rigorous training in radiation safety and wear protective gear, such as dosimeters, to monitor exposure levels. Personal protective equipment and safe handling of radioactive materials are essential for staff during procedures like brachytherapy. By implementing these safety measures, the risk of radiation-related side effects and complications is minimized, ensuring safer treatment outcomes in oncology.

Session 15Integrating Radiology and Oncology for Effective Treatment

Integrating radiology and oncology is essential for providing effective cancer treatment, as it combines advanced imaging techniques with personalized cancer care. Radiology plays a key role in diagnosing cancer, determining tumor location and size, and assessing metastasis using tools such as CT, MRI, PET/CT, and ultrasound. By collaborating closely with oncologists, radiologists help design precise treatment plans, including radiation therapy, surgery, and chemotherapy, tailored to the tumor’s characteristics. This integration also enables real-time monitoring of treatment response, detecting recurrence, and adjusting therapies accordingly. Advances in molecular imaging and AI further enhance this collaboration, offering more accurate diagnostics and personalized treatment strategies. The synergy between radiology and oncology improves patient outcomes by ensuring that therapies are delivered more precisely and effectively, with continuous adjustments based on imaging data. This multidisciplinary approach is a cornerstone of modern cancer care, maximizing treatment efficacy while minimizing side effects.

Session 16The Future of Immunotherapy and Radiology

The future of immunotherapy and radiology lies in their integration to enhance cancer treatment. Immunotherapy, which leverages the body’s immune system to fight cancer, is increasingly being combined with radiology techniques to improve outcomes. Radiation therapy can create a more favorable tumor microenvironment, making cancer cells more susceptible to immune system attack. Conversely, immunotherapy can enhance the effectiveness of radiation by boosting immune responses to the irradiated tumor. Advances in imaging, such as PET/CT and MRI, enable real-time monitoring of tumor response to combined therapies, guiding treatment adjustments. Radiomics and AI are also being used to predict which patients will benefit most from the combination of immunotherapy and radiotherapy. Personalized treatment plans that incorporate both modalities promise to offer more targeted, effective, and less toxic cancer treatments. As research progresses, this synergistic approach holds the potential to transform cancer care, providing new hope for patients with difficult-to-treat cancers.

Session 17Radiotherapy in Metastatic Cancer Management

Radiotherapy plays a crucial role in the management of metastatic cancer by controlling tumor growth, alleviating symptoms, and improving quality of life. It is often used to treat isolated metastatic lesions, particularly in the brain, spine, bones, and lungs, where it can reduce tumor size and prevent further spread. Techniques like stereotactic body radiotherapy (SBRT) and whole-brain radiation therapy (WBRT) deliver precise doses of radiation to metastatic sites, minimizing damage to surrounding healthy tissue. Radiotherapy can also be combined with systemic treatments like chemotherapy and immunotherapy to enhance overall efficacy. In patients with widespread metastases, palliative radiotherapy helps manage pain, bleeding, and obstruction, improving comfort. Personalized treatment plans, guided by advanced imaging and tumor characteristics, ensure targeted therapy. While it may not cure metastatic cancer, radiotherapy helps control the disease and extend survival in many patients. The integration of radiotherapy with emerging therapies continues to improve outcomes in metastatic cancer management.

Session 18Challenges in Cancer Imaging for Pediatric Patients

Session 19Radiology in Lung Cancer Detection and Treatment

Radiology plays a pivotal role in the detection and treatment of lung cancer by providing detailed images that guide diagnosis, staging, and treatment planning. Techniques such as low-dose CT scans are used for early detection in high-risk individuals, offering a non-invasive way to identify small nodules before symptoms arise. For diagnosis, CT and PET/CT imaging help in determining tumor size, location, and spread to nearby lymph nodes or distant organs. These imaging methods are also crucial in guiding biopsy procedures to obtain tissue samples for further analysis. In treatment planning, radiology aids in precise radiation therapy delivery, minimizing damage to healthy tissue. Advanced techniques, like stereotactic body radiotherapy (SBRT), provide highly focused radiation to tumors, improving efficacy while reducing side effects. MRI and CT scans are also used to monitor treatment response and detect recurrence. Radiology’s integration with other modalities, like molecular imaging, further enhances personalized care, optimizing outcomes for lung cancer patients.

Session 20Role of Imaging in Breast Cancer Diagnosis

Imaging plays a critical role in the diagnosis and management of breast cancer by helping detect, evaluate, and monitor tumors. Mammography is the most widely used imaging technique for routine breast cancer screening, capable of identifying tumors before they can be felt physically. Ultrasound is often used alongside mammography to assess the characteristics of breast lesions and guide biopsy procedures for tissue sampling. MRI is particularly useful in high-risk patients, assessing tumor size and detecting cancers that may not be visible on mammograms. Additionally, molecular imaging techniques like PET/CT can help assess the extent of cancer spread and monitor treatment response. Advances in 3D imaging, such as digital breast tomosynthesis (DBT), provide clearer, more detailed images, improving detection rates, especially in dense breast tissue. Imaging also plays a key role in treatment planning for radiation therapy and surgery, ensuring precise targeting of tumors while preserving healthy tissue. These advancements enable early detection, accurate diagnosis, and personalized treatment strategies for breast cancer patients.

Session 21Innovations in Radiology for Prostate Cancer

Innovations in radiology have significantly improved the detection, diagnosis, and treatment of prostate cancer. Multiparametric MRI (mpMRI) is now the gold standard for detecting and localizing prostate tumors, providing detailed images of both the prostate’s anatomy and its biochemical characteristics. It allows for better differentiation between benign and malignant lesions, guiding biopsy procedures more accurately. PET/CT imaging using prostate-specific radiotracers, such as PSMA (prostate-specific membrane antigen), is enhancing tumor detection, particularly in cases of biochemical recurrence and metastatic spread. These advanced imaging techniques help determine the extent of cancer and plan precise radiation therapy, minimizing damage to surrounding tissues. Additionally, imaging-guided robotic surgery and focal therapy enable more precise treatment delivery. The integration of artificial intelligence (AI) with radiology is improving image interpretation and aiding in early cancer detection, reducing human error and providing more accurate diagnostic outcomes. These innovations lead to better-targeted treatments and improved survival rates for prostate cancer patients.

Session 22Radiotherapy in Gynecological Cancers

Radiotherapy plays a crucial role in the treatment of gynecological cancers, including cancers of the cervix, uterus, ovaries, and vulva. It is commonly used as a primary treatment for cervical cancer, where external beam radiation therapy (EBRT) is combined with brachytherapy (internal radiation) to deliver targeted doses to the tumor while minimizing exposure to surrounding healthy tissues. In endometrial cancer, radiotherapy is often used post-surgery to eliminate any remaining cancer cells and reduce the risk of recurrence. For ovarian cancer, radiotherapy is typically used in combination with chemotherapy, targeting any remaining tumor tissue after surgery. Advances in imaging techniques, such as MRI and CT, have enhanced the precision of radiotherapy, allowing for more accurate tumor targeting and reducing side effects. Intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT) further improve treatment delivery by conforming the radiation dose to the shape and size of the tumor. These advancements help provide more effective, personalized treatment options for patients with gynecological cancers.

Session 23Advances in Imaging for Brain Tumors

Advances in imaging have greatly improved the diagnosis, treatment planning, and monitoring of brain tumors. Magnetic resonance imaging (MRI) remains the gold standard for visualizing brain tumors, offering high-resolution images that provide detailed views of tumor size, location, and involvement with surrounding brain structures. Functional MRI (fMRI) and diffusion tensor imaging (DTI) help map critical brain areas, allowing surgeons to avoid damaging important regions during tumor removal. Positron emission tomography (PET) and PET/CT imaging provide insights into the metabolic activity of tumors, helping differentiate between benign and malignant growths. Advanced techniques like MR spectroscopy and contrast-enhanced imaging allow for better characterization of tumor types and can guide biopsy decisions. Stereotactic radiosurgery, assisted by advanced imaging, delivers precise radiation to tumors, minimizing damage to healthy tissue. Additionally, the integration of artificial intelligence (AI) in imaging analysis improves diagnostic accuracy and aids in predicting tumor behavior, further enhancing personalized treatment strategies for brain tumor patients

Session 24Radiotherapy and Tumor Microenvironment

Radiotherapy interacts with the tumor microenvironment (TME) in complex ways, influencing both tumor cells and the surrounding supportive structures. The TME includes stromal cells, blood vessels, immune cells, and extracellular matrix, all of which affect tumor progression and response to treatment. Radiotherapy induces tumor cell death through DNA damage, but it also alters the TME by promoting inflammation, hypoxia, and the release of growth factors that can influence tumor survival and metastasis. Hypoxia, in particular, reduces the effectiveness of radiation, as tumor cells in low-oxygen conditions are more resistant to damage. Advances in radiotherapy techniques, such as combining radiation with therapies targeting the TME (e.g., immune checkpoint inhibitors or agents that improve oxygen delivery), aim to enhance treatment efficacy. Understanding and modulating the TME is critical for improving radiotherapy outcomes, as it can help overcome resistance, promote immune response, and ensure better tumor control. These strategies are at the forefront of research in making radiotherapy more effective in combating resistant cancers.

Session 25The Impact of Radiology on Cancer Survival Rates

Radiology also plays a pivotal role in guiding minimally invasive procedures like biopsies and radiation therapy, ensuring targeted treatment with minimal damage to surrounding healthy tissues. Innovations in radiologic imaging, such as functional imaging and AI-assisted diagnostics, have further improved treatment planning and real-time monitoring of therapy effectiveness, leading to improved outcomes and prolonged survival rates for cancer patients.

Session 26Chemoradiation in Cancer Therapy

Chemoradiation combines chemotherapy and radiation therapy to treat cancer, offering a powerful approach to controlling and eradicating tumors. Chemotherapy makes cancer cells more sensitive to radiation, enhancing its effectiveness in destroying them. This dual therapy is commonly used for cancers like head and neck, cervical, lung, and rectal cancers, particularly in locally advanced stages. While it improves survival rates and reduces the need for surgery in some cases, chemoradiation may cause side effects, such as fatigue, skin irritation, and organ-specific toxicity, which require careful management for optimal outcomes.

Session 27Imaging in Cancer Recurrence Detection

Imaging is essential in detecting cancer recurrence, enabling early identification and management of cancer’s return after treatment. Techniques like CT scans, MRIs, and PET scans provide detailed insights into tumor location, size, and activity, distinguishing between scar tissue and active disease. PET/CT is particularly valuable for identifying metabolic changes associated with recurrent cancer. Regular imaging helps monitor high-risk patients, confirm suspected recurrences, and guide subsequent therapies or biopsies. Early detection through imaging improves treatment planning and enhances the likelihood of favorable outcomes.

Session 28Challenges in Cancer Radiology for Low-Resource Settings

Cancer radiology in low-resource settings faces significant challenges that hinder effective diagnosis and treatment. Limited access to advanced imaging technologies like CT, MRI, and PET scans often delays detection and staging of cancers. Insufficient infrastructure, a lack of trained radiologists, and frequent equipment breakdowns further exacerbate the issue. High costs of imaging systems and maintenance make them inaccessible for many healthcare facilities, while inconsistent power supplies and poor internet connectivity hinder digital radiology and telemedicine solutions. Addressing these challenges requires strategic investments in affordable technologies, training programs, and partnerships to improve cancer care accessibility in underserved regions.

Session 29The Intersection of Radiology and Cancer Surgery

The intersection of radiology and cancer surgery plays a pivotal role in enhancing surgical precision and improving patient outcomes. Preoperative imaging, such as CT, MRI, and ultrasound, helps surgeons accurately assess tumor size, location, and involvement with surrounding tissues, enabling better surgical planning. Intraoperative imaging technologies, like fluoroscopy and real-time ultrasound, guide surgeons during procedures to ensure precise tumor removal while preserving healthy tissue. Postoperative imaging is also critical for monitoring recovery and detecting any residual disease. This integration of radiology with surgery optimizes cancer treatment, reduces complications, and improves survival rates.

Session 30The Future of Cancer Radiology: Emerging Technologies

The future of cancer radiology is being shaped by emerging technologies that promise greater precision, efficiency, and personalized care. Artificial intelligence (AI) and machine learning are revolutionizing diagnostics by enabling faster and more accurate detection of tumors, even in early stages. Advances in functional imaging, such as PET/MRI and molecular imaging, provide detailed insights into tumor biology, aiding tailored treatment plans. Technologies like radiomics and theranostics are integrating imaging with therapy, allowing real-time monitoring of treatment efficacy. Additionally, portable imaging devices and telemedicine platforms are improving accessibility, especially in remote and underserved areas, transforming cancer care globally.